ArticleMolecular medicine (Cambridge, Mass.)2023

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.

Elizabeth J Wilk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.